Nice review --> Pursuit of a perfect insulinhttps://t.co/Up2E6aVzoC$NVO $SNY $LLY pic.twitter.com/vxSEizNIT7
— Andy Biotech (@AndyBiotech) March 22, 2016
$INCY $LLY Baricitinib Ph3 RA-BEACON data published in NEJM https://t.co/mJF1a1JuAw pic.twitter.com/hU8lxprXnT
— Andy Biotech (@AndyBiotech) March 31, 2016
Most popular on https://t.co/4NNEmdSsxY now: The Science of Choosing Wisely — Overcoming the Therapeutic Illusion. https://t.co/4apTRezGvR
— NEJM (@NEJM) April 1, 2016
Human serotonin transporter (SERT) structure finally solvedhttps://t.co/khwQK2Wftyhttps://t.co/fXVnFkJJqN pic.twitter.com/5gSUVUdYFo
— Andy Biotech (@AndyBiotech) April 7, 2016
New Paper on CRISPR of Human Embryos Highlights Serious Tech Problems https://t.co/OcLknbFp2F pic.twitter.com/dvBaawSswc
— Paul Knoepfler (@pknoepfler) April 8, 2016
New review on drugging metastasis: 'overt scepticism exists in biopharma and academia' https://t.co/qQOkR1o5LO □ pic.twitter.com/RsZ05c14BY
— Arsalan Arif (@AKAarsalan) April 12, 2016
Important #Zika development @NEJM. Never in humans have we seen illness spread by mosquitoes linked to birth defect. https://t.co/AM92nXjuGe
— Dr. Tom Frieden (@DrFriedenCDC) April 13, 2016
Good review relevant to $12B Samumed -> Can we safely target the WNT pathway?https://t.co/ZM6gsuzwJY
— Andy Biotech (@AndyBiotech) April 14, 2016
HT @Sport234a pic.twitter.com/hCGBQKcAN7